710 Medtronic Parkway, NE
Medtronic, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world.
Founders: Earl Bakken and Palmer Hermundlie
CEO: Omar Ishrak
CFO: Karen Parkhill
CSO (Scientific): Richard Kuntz
Please click here for Medtronic job opportunities.
Tweets by Medtronic
2110 articles with Medtronic
7/25/2019Biotech and pharma companies from across the globe provide updates on company strategy and pipeline developments.
Top 5 Vendors in the Transcatheter Embolization and Occlusion Devices Market from 2019 to 2023 | Technavio
The need for quality patient care has increased owing to the growing aging population and the consequent rise in chronic diseases.
Chronic sinusitis and bacteria-caused sinus infections are the most prevalent health issues witnessed in various countries.
Health Canada is advising patients and health care providers that certain older Medtronic MiniMed 508 and MiniMed Paradigm insulin pumps distributed between 2010 and 2015, may be vulnerable to cybersecurity risks.
Saluda Medical Pty Limited announced that it has secured a four-year term loan agreement with Medtronic, to fund continued development of its Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System for the treatment of chronic intractable pain of the trunk and limbs.
Medtronic Announces Cash Tender Offers for up to $4.175 Billion of Outstanding Debt Securities Issued by Medtronic, Inc., Medtronic Global Holdings S.C.A. and Covidien International Finance S.A.
Medtronic plc announced the commencement of two cash tender offers by its wholly-owned indirect subsidiaries, Medtronic, Inc., Medtronic Global Holdings S.C.A. and Covidien International Finance S.A. ("CIFSA" and, together with Medtronic, Inc.
The board of directors of Medtronic plc approved an 8 percent increase in its quarterly cash dividend, raising the quarterly amount to $0.54 per ordinary share.
Medtronic Announces Its Forthcoming Robotic Assisted Surgical Platform to Feature Three-Dimensional Vision System from KARL STORZ
To enable upcoming regulatory filings, Medtronic plc made public its partnership with KARL STORZ SE & Co. KG, a pioneer in the field of endoscopic imaging.
Sugar.IQ Insights Viewed as Helpful and Enable Users to Avoid Diabetes-Related Events up to Four Hours in Advance
Medtronic Initiates Pivotal Trial for Next-Generation Guardian(TM) Continuous Glucose Monitoring Sensor
Medtronic plc, the global leader in medical technology, announced that it has initiated the company's pivotal trial for its next-generation Guardian continuous glucose monitoring sensor designed to improve accuracy and overall system performance, reduce sensor calibrations and enhance overall user experience.
Medtronic Initiates Pivotal Trial for Bluetooth Enabled MiniMed(TM) 780G Advanced Hybrid Closed Loop System Designed to Automate Correction Bolusing
Medtronic plc, the global leader in medical technology, announced the enrollment of the first study participants in the company's pivotal trial of its Bluetooth® enabled MiniMed 780G advanced hybrid closed loop system.
Medtronic and Tidepool Work Together on Interoperable Automated Insulin Pump System for Diabetes Management
Medtronic plc, the global leader in medical technology, services and solutions, and Tidepool, a 501 nonprofit organization dedicated to making diabetes data more accessible, actionable and meaningful, have agreed to work together to create an interoperable automated insulin pump system.
Medtronic plc, the global leader in medical technology, announced that it will participate in the Goldman Sachs 40th Annual Global Healthcare Conference on Tuesday, June 11, 2019, in Rancho Palos Verdes, California.
Medtronic plc announced U.S. Food and Drug Administration clearance and commercial launch for the SelectSite C304-HIS deflectable catheter system for use in procedures involving His-bundle pacing.
MiniMed(TM) 670G System Real-World Data on 8 Million Patient Days Shows 71 Percent Time in Range Across All Age Groups
Medtronic plc, the global leader in medical technology, announced real-world clinical outcomes for the MiniMed 670G system, which is being used by more than 180,000 people.
Medtronic plc, the global leader in medical technology, announced it will participate in the Jefferies 2019 Global Healthcare Conference on Wednesday, June 5, 2019, in New York City.
Medtronic Chairman and CEO Omar Ishrak to Speak at the 35th Annual Bernstein Strategic Decisions Conference
Medtronic plc, the global leader in medical technology, announced that it will participate in the Bernstein 35th Annual Strategic Decisions Conference on Wednesday, May 29, 2019, in New York City.
Medtronic plc announced financial results for its fiscal year and fourth quarter 2019, which ended April 26, 2019.
Results Announced from Two Renal Denervation Studies at EuroPCR Show Positive Outcomes in High-Risk Hypertensive Patients
Late-Breaking Clinical Trial Results and Updated Global SYMPLICITY Registry Data Demonstrate Long-Term Results of RDN for Uncontrolled Hypertension
FDA Cleared and CE Marked, Telescope Enters Global Market with Design Innovations to Enable Smooth Delivery of Coronary Stents and Balloons